Pyoderma gangrenosum treated with cyclosporin A

British Journal of Dermatology

Volumn 113, Issue 5, 1985, Pages 601-604

  CURLEY, R K ^a   MACFARLANE, A W ^a   VICKERS, C F H ^a  

^a Royal Liverpool Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; CHLORPROPAMIDE; CLOFAZIMINE; CORTICOTROPIN; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; DIPYRIDAMOLE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

CASE REPORT; DRUG THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; THERAPY;

ADULT; CASE REPORT; CYCLOSPORINS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; PYODERMA; SKIN ULCER;

EID: 0022383941     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1985.tb02385.x     Document Type: Article

References (6)

1. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers
2. T helper‐suppressor cell imbalance in pyoderma gangrenosum with relapsing polychondritis and corneal keratolysis
3. Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European Multicentre Trial
4. Dermatological aspects of the use of cyclosporin A for the prophylaxis of graft‐versus‐host disease
5. Cyclosporin‐associated chronic nephropathy
6. Side effects of systemic cyclosporin in patients not undergoing transplantation